APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tetrahydrocannabinol (THC) and Cannabidiol (CBD)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Research Report 2026

Report ID 174040610519 December 2025144 pages

Choose your research edition.

Industry ResearchTetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tetrahydrocannabinol (THC) and Cannabidiol (CBD) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) include Whistler, The Lab, Select Oil, Pharmahemp, NuLeaf Naturals, Medical Marijuana, Kazmira, K.I.N.D. Concentrates and HempLife Today, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market by Company

Whistler

The Lab

Select Oil

Pharmahemp

NuLeaf Naturals

Medical Marijuana

Kazmira

K.I.N.D. Concentrates

HempLife Today

Green Road

Freedom Leaf

Folium Biosciences

ENDOCA

Emblem Cannabis Oils

CW Hemp/CW Botanicals

CBD American Shaman

Canopy Growth Corporation

Cannavest

Aphria

Absolute Terps

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Type

Tetrahydrocannabinol (THC)

Cannabidiol (CBD)

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Application

Pharmaceuticals Industry

Food Industry

Cosmetics Industry

Other

Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tetrahydrocannabinol (THC) and Cannabidiol (CBD) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue of Manufacturers (2021-2026) Table 9. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price (US$/Ton) of Manufacturers (2021-2026) Table 11. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Product Type & Application Table 14. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Whistler Company Information Table 19. Whistler Business Overview Table 20. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 21. Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 22. Whistler Recent Developments Table 23. The Lab Company Information Table 24. The Lab Business Overview Table 25. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 26. The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 27. The Lab Recent Developments Table 28. Select Oil Company Information Table 29. Select Oil Business Overview Table 30. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 31. Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 32. Select Oil Recent Developments Table 33. Pharmahemp Company Information Table 34. Pharmahemp Business Overview Table 35. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 36. Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 37. Pharmahemp Recent Developments Table 38. NuLeaf Naturals Company Information Table 39. NuLeaf Naturals Business Overview Table 40. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 41. NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 42. NuLeaf Naturals Recent Developments Table 43. Medical Marijuana Company Information Table 44. Medical Marijuana Business Overview Table 45. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 47. Medical Marijuana Recent Developments Table 48. Kazmira Company Information Table 49. Kazmira Business Overview Table 50. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 52. Kazmira Recent Developments Table 53. K.I.N.D. Concentrates Company Information Table 54. K.I.N.D. Concentrates Business Overview Table 55. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 57. K.I.N.D. Concentrates Recent Developments Table 58. HempLife Today Company Information Table 59. HempLife Today Business Overview Table 60. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 62. HempLife Today Recent Developments Table 63. Green Road Company Information Table 64. Green Road Business Overview Table 65. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 67. Green Road Recent Developments Table 68. Freedom Leaf Company Information Table 69. Freedom Leaf Business Overview Table 70. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 72. Freedom Leaf Recent Developments Table 73. Folium Biosciences Company Information Table 74. Folium Biosciences Business Overview Table 75. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 77. Folium Biosciences Recent Developments Table 78. ENDOCA Company Information Table 79. ENDOCA Business Overview Table 80. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 82. ENDOCA Recent Developments Table 83. Emblem Cannabis Oils Company Information Table 84. Emblem Cannabis Oils Business Overview Table 85. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 86. Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 87. Emblem Cannabis Oils Recent Developments Table 88. CW Hemp/CW Botanicals Company Information Table 89. CW Hemp/CW Botanicals Business Overview Table 90. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 91. CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 92. CW Hemp/CW Botanicals Recent Developments Table 93. CBD American Shaman Company Information Table 94. CBD American Shaman Business Overview Table 95. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 96. CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 97. CBD American Shaman Recent Developments Table 98. Canopy Growth Corporation Company Information Table 99. Canopy Growth Corporation Business Overview Table 100. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 101. Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 102. Canopy Growth Corporation Recent Developments Table 103. Cannavest Company Information Table 104. Cannavest Business Overview Table 105. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 106. Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 107. Cannavest Recent Developments Table 108. Aphria Company Information Table 109. Aphria Business Overview Table 110. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 111. Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 112. Aphria Recent Developments Table 113. Absolute Terps Company Information Table 114. Absolute Terps Business Overview Table 115. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 116. Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio Table 117. Absolute Terps Recent Developments Table 118. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2021-2026) & (Tons) Table 120. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2021-2026) Table 121. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region (2027-2032) & (Tons) Table 122. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Region (2027-2032) Table 123. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2021-2026) Table 125. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Region (2027-2032) Table 127. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 129. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 130. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 134. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 135. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 139. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 140. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 144. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 145. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2026) & (Tons) Table 149. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2027-2032) & (Tons) Table 150. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2026) & (Tons) Table 153. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2027-2032) & (Tons) Table 154. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2026) Table 155. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2027-2032) Table 156. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2026) Table 159. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2027-2032) Table 160. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2026) & (US$/Ton) Table 161. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2027-2032) & (US$/Ton) Table 162. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2026) & (Tons) Table 163. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2027-2032) & (Tons) Table 164. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2026) Table 165. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2027-2032) Table 166. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2026) Table 169. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2027-2032) Table 170. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2026) & (US$/Ton) Table 171. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2027-2032) & (US$/Ton) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors List Table 175. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers List Table 176. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends Table 177. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers Table 178. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Image Figure 5. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (2021-2032) & (US$ Million) Figure 7. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032) & (Tons) Figure 8. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price (US$/Ton) & (2021-2032) Figure 9. Tetrahydrocannabinol (THC) Product Image Figure 10. Cannabidiol (CBD) Product Image Figure 11. Pharmaceuticals Industry Product Image Figure 12. Food Industry Product Image Figure 13. Cosmetics Industry Product Image Figure 14. Other Product Image Figure 15. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Share by Manufacturers in 2025 Figure 16. Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Manufacturing Sites & Headquarters Figure 17. Global Top 5 and 10 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Players Market Share by Revenue in 2025 Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 20. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region in 2025 Figure 21. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region in 2025 Figure 22. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country in 2025 Figure 23. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 24. North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2021-2032) Figure 25. United States Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Canada Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country in 2025 Figure 28. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 29. Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2021-2032) Figure 30. Germany Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Netherlands Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country in 2025 Figure 36. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 37. Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2021-2032) Figure 38. China Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Japan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. South Korea Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. India Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Australia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. China Taiwan Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Southeast Asia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country in 2025 Figure 47. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 48. South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2021-2032) Figure 49. Mexico Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Brazil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Argentina Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country in 2025 Figure 53. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Country (2021-2032) Figure 54. Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Country (2021-2032) Figure 55. Turkey Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Saudi Arabia Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. UAE Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032) Figure 59. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032) Figure 60. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price (US$/Ton) by Type (2021-2032) Figure 61. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032) Figure 62. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032) Figure 63. Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price (US$/Ton) by Application (2021-2032) Figure 64. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Figure 65. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process Figure 66. Direct Comparison with Distribution Share Figure 67. Distributors Profiles Figure 68. Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Tetrahydrocannabinol (THC)
  • Cannabidiol (CBD)
Applications
  • Pharmaceuticals Industry
  • Food Industry
  • Cosmetics Industry
  • Other
Companies covered
  • Whistler
  • The Lab
  • Select Oil
  • Pharmahemp
  • NuLeaf Naturals
  • Medical Marijuana
  • Kazmira
  • K.I.N.D. Concentrates
  • HempLife Today
  • Green Road
  • Freedom Leaf
  • Folium Biosciences
  • ENDOCA
  • Emblem Cannabis Oils
  • CW Hemp/CW Botanicals
  • CBD American Shaman
  • Canopy Growth Corporation
  • Cannavest
  • Aphria
  • Absolute Terps

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size (2021-2032)
  4. 2.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (2021-2032)
  5. 2.2.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Average Price (2021-2032)
  6. 2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Tetrahydrocannabinol (THC)
  9. 2.3.3 Cannabidiol (CBD)
  10. 2.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Pharmaceuticals Industry
  13. 2.4.3 Food Industry
  14. 2.4.4 Cosmetics Industry
  15. 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Product Type & Application
  8. 3.8 Global Manufacturers of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), Established Date
  9. 3.9 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Whistler
  2. 4.1.1 Whistler Company Information
  3. 4.1.2 Whistler Business Overview
  4. 4.1.3 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Whistler Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  6. 4.1.5 Whistler Recent Developments
  7. 4.2 The Lab
  8. 4.2.1 The Lab Company Information
  9. 4.2.2 The Lab Business Overview
  10. 4.2.3 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 The Lab Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  12. 4.2.5 The Lab Recent Developments
  13. 4.3 Select Oil
  14. 4.3.1 Select Oil Company Information
  15. 4.3.2 Select Oil Business Overview
  16. 4.3.3 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Select Oil Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  18. 4.3.5 Select Oil Recent Developments
  19. 4.4 Pharmahemp
  20. 4.4.1 Pharmahemp Company Information
  21. 4.4.2 Pharmahemp Business Overview
  22. 4.4.3 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Pharmahemp Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  24. 4.4.5 Pharmahemp Recent Developments
  25. 4.5 NuLeaf Naturals
  26. 4.5.1 NuLeaf Naturals Company Information
  27. 4.5.2 NuLeaf Naturals Business Overview
  28. 4.5.3 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NuLeaf Naturals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  30. 4.5.5 NuLeaf Naturals Recent Developments
  31. 4.6 Medical Marijuana
  32. 4.6.1 Medical Marijuana Company Information
  33. 4.6.2 Medical Marijuana Business Overview
  34. 4.6.3 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Medical Marijuana Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  36. 4.6.5 Medical Marijuana Recent Developments
  37. 4.7 Kazmira
  38. 4.7.1 Kazmira Company Information
  39. 4.7.2 Kazmira Business Overview
  40. 4.7.3 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kazmira Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  42. 4.7.5 Kazmira Recent Developments
  43. 4.8 K.I.N.D. Concentrates
  44. 4.8.1 K.I.N.D. Concentrates Company Information
  45. 4.8.2 K.I.N.D. Concentrates Business Overview
  46. 4.8.3 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 K.I.N.D. Concentrates Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  48. 4.8.5 K.I.N.D. Concentrates Recent Developments
  49. 4.9 HempLife Today
  50. 4.9.1 HempLife Today Company Information
  51. 4.9.2 HempLife Today Business Overview
  52. 4.9.3 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 HempLife Today Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  54. 4.9.5 HempLife Today Recent Developments
  55. 4.10 Green Road
  56. 4.10.1 Green Road Company Information
  57. 4.10.2 Green Road Business Overview
  58. 4.10.3 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Green Road Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  60. 4.10.5 Green Road Recent Developments
  61. 4.11 Freedom Leaf
  62. 4.11.1 Freedom Leaf Company Information
  63. 4.11.2 Freedom Leaf Business Overview
  64. 4.11.3 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Freedom Leaf Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  66. 4.11.5 Freedom Leaf Recent Developments
  67. 4.12 Folium Biosciences
  68. 4.12.1 Folium Biosciences Company Information
  69. 4.12.2 Folium Biosciences Business Overview
  70. 4.12.3 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Folium Biosciences Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  72. 4.12.5 Folium Biosciences Recent Developments
  73. 4.13 ENDOCA
  74. 4.13.1 ENDOCA Company Information
  75. 4.13.2 ENDOCA Business Overview
  76. 4.13.3 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 ENDOCA Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  78. 4.13.5 ENDOCA Recent Developments
  79. 4.14 Emblem Cannabis Oils
  80. 4.14.1 Emblem Cannabis Oils Company Information
  81. 4.14.2 Emblem Cannabis Oils Business Overview
  82. 4.14.3 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Emblem Cannabis Oils Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  84. 4.14.5 Emblem Cannabis Oils Recent Developments
  85. 4.15 CW Hemp/CW Botanicals
  86. 4.15.1 CW Hemp/CW Botanicals Company Information
  87. 4.15.2 CW Hemp/CW Botanicals Business Overview
  88. 4.15.3 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 CW Hemp/CW Botanicals Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  90. 4.15.5 CW Hemp/CW Botanicals Recent Developments
  91. 4.16 CBD American Shaman
  92. 4.16.1 CBD American Shaman Company Information
  93. 4.16.2 CBD American Shaman Business Overview
  94. 4.16.3 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 CBD American Shaman Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  96. 4.16.5 CBD American Shaman Recent Developments
  97. 4.17 Canopy Growth Corporation
  98. 4.17.1 Canopy Growth Corporation Company Information
  99. 4.17.2 Canopy Growth Corporation Business Overview
  100. 4.17.3 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Canopy Growth Corporation Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  102. 4.17.5 Canopy Growth Corporation Recent Developments
  103. 4.18 Cannavest
  104. 4.18.1 Cannavest Company Information
  105. 4.18.2 Cannavest Business Overview
  106. 4.18.3 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Cannavest Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  108. 4.18.5 Cannavest Recent Developments
  109. 4.19 Aphria
  110. 4.19.1 Aphria Company Information
  111. 4.19.2 Aphria Business Overview
  112. 4.19.3 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Aphria Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  114. 4.19.5 Aphria Recent Developments
  115. 4.20 Absolute Terps
  116. 4.20.1 Absolute Terps Company Information
  117. 4.20.2 Absolute Terps Business Overview
  118. 4.20.3 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Absolute Terps Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Product Portfolio
  120. 4.20.5 Absolute Terps Recent Developments
5 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Scenario by Region
  1. 5.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021-2032
  3. 5.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2021-2026
  4. 5.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Region: 2027-2032
  5. 5.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region: 2021-2032
  6. 5.3.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region: 2021-2026
  7. 5.3.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Region: 2027-2032
  8. 5.4 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
  9. 5.4.1 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  11. 5.4.3 North America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
  15. 5.5.1 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  17. 5.5.3 Europe Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
  35. 5.7.1 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  37. 5.7.3 South America Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032)
  2. 6.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Type (2021-2032)
  5. 6.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032)
  2. 7.1.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue by Application (2021-2032)
  5. 7.2.1 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Value Chain Analysis
  2. 8.1.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Production Mode & Process
  5. 8.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Distributors
  8. 8.2.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Customers
9 Global Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Analyzing Market Dynamics
  1. 9.1 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Trends
  2. 9.2 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Drivers
  3. 9.3 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Opportunities and Challenges
  4. 9.4 Tetrahydrocannabinol (THC) and Cannabidiol (CBD) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst